chlorpropamide has been researched along with Shock in 2 studies
Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.
Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
BAUER, HG | 1 |
Ciechanowski, K | 1 |
Borowiak, KS | 1 |
Potocka, BA | 1 |
Nowacka, M | 1 |
Dutkiewicz, G | 1 |
2 other studies available for chlorpropamide and Shock
Article | Year |
---|---|
SEVERE AND PROLONGED HYPOGLYCEMIC SHOCK DURING SULFONYLUREA TREATMENT.
Topics: Acetohexamide; Chlorpropamide; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Coma; Geriatrics; | 1965 |
Chlorpropamide toxicity with survival despite 27-day hypoglycemia.
Topics: Adult; Chlorpropamide; Electrocardiography; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Respi | 1999 |